Clinical Trial Update: Initial Chronic Human Validation Study: Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) System [NA]

View source ↗

Summary

A completed clinical trial update for the Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) system investigating ventricular tachyarrhythmias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachyarrhythmia

Drugs mentioned

• Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) system

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Ventricular Tachyarrhythmias | NA | Status: COMPLETED | Results posted: 2021-06-29